Compare INVH & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INVH | MEDP |
|---|---|---|
| Founded | 2012 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.2B | 15.4B |
| IPO Year | 2016 | 2016 |
| Metric | INVH | MEDP |
|---|---|---|
| Price | $29.78 | $601.38 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 18 | 12 |
| Target Price | $32.50 | ★ $473.17 |
| AVG Volume (30 Days) | ★ 4.0M | 344.2K |
| Earning Date | 04-29-2026 | 04-22-2026 |
| Dividend Yield | ★ 4.28% | N/A |
| EPS Growth | ★ 29.73 | 20.98 |
| EPS | 0.26 | ★ 8.53 |
| Revenue | ★ $2,729,296,000.00 | N/A |
| Revenue This Year | $2.92 | $13.19 |
| Revenue Next Year | $2.43 | $7.75 |
| P/E Ratio | ★ $113.23 | $141.55 |
| Revenue Growth | ★ 4.21 | N/A |
| 52 Week Low | $24.25 | $373.00 |
| 52 Week High | $32.05 | $677.90 |
| Indicator | INVH | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 50.03 | 76.05 |
| Support Level | $29.29 | $577.01 |
| Resistance Level | $30.12 | $622.32 |
| Average True Range (ATR) | 0.52 | 20.81 |
| MACD | -0.09 | 3.71 |
| Stochastic Oscillator | 30.80 | 58.12 |
Invitation Homes owns a portfolio of over 85,000 single-family rental homes. The company focuses on owning homes in the starter and move-up segments of the housing market with an average sale price around $350,000 and generally less than 1,800 square feet. The portfolio is spread across 17 target markets that feature high employment and household formation growth with over 70% of the portfolio in the Western US and Florida; 15 of the 17 markets featuring average rents lower than homeownership costs.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.